期刊文献+

细菌外膜囊泡在疾病治疗与预防中的应用 被引量:3

Application of bacterial outer membrane vesicles in the treatment and prevention of diseases
原文传递
导出
摘要 细菌外膜囊泡(outer membrane vesicles,OMVs)是细菌产生的由膜包裹的纳米结构,具有非复制性,影响多种生物过程,包括毒力因子的运输、DNA转移、噬菌体的拦截、抗生素和真核宿主防御因子、细胞解毒、细胞代谢物输出、细胞间通讯等。OMVs具有细菌源性、免疫原性、稳定性以及同源靶向性等优势,这使运用OMVs进行疾病治疗与预防具有较好的应用前景。本文基于OMVs的生物学特性、提取方法、脱毒方法以及疾病治疗与预防等方面进行综述,以期为OMVs的应用提供参考。 Bacterial outer membrane vesicles(OMVs)are membrane-wrapped nanostructures produced by bacteria,which are non-replicative and affect a variety of biological processes,including virulence factor transport,DNA transfer,phage interception,antibiotic and eukaryotic host defense factors,cell detoxification,cell metabolite output,and intercellular communication.OMVs have the advantages of bacterial origin,immunogenicity,stability,homologous targeting and so on,which make the application of OMVs with potential applications in disease treatment.The biological characteristics,extraction methods,detoxification methods,disease treatment and prevention of OMVs were reviewed in order to provide reference for the application of OMVs.
作者 刘昕 买冰洁 郭晓瑜 常亚炜 王攀 LIU Xin;MAI Bingjie;GUO Xiaoyu;CHANG Yawei;WANG Pan(College of Life Science,Shaanxi Normal University,Xi'an 710119,China)
出处 《生命的化学》 CAS 2022年第2期250-258,共9页 Chemistry of Life
基金 国家自然科学基金项目(81872497)。
关键词 细菌外膜囊泡 肿瘤治疗 抗菌 疫苗 bacterial outer membrane vesicles cancer treatment antibacterial vaccine
  • 相关文献

参考文献1

二级参考文献17

  • 1Beveridge TJ. Structures of gram-negative cell walls and their derived membrane vesicles [J]. J Bacteriol, 1999, 181 (16) : 4725 - 4733.
  • 2Bishop DC, Work E. An extracellular glycolipid produced by Escherichia coli grown under Lysine-limiLing conditions [J]. Biochem J, 1965, 96 (2) : 567 - 576.
  • 3Deatherage BL, Cookson BT. Membrane vesicle release in bacteria. eukaryotes , and archaea . a conserved yet underappreciated aspect of microbiallife[J]. Infect immun , 2012, 80(6): 1948 -1957.
  • 4Kulp A, Kuehn MJ. Biological functions and biogenesis of secreted bacterial outer membrane vesicles[J]. Annu Rev M icrobiol , 2010, 64: 163 - 184.
  • 5Ellis TN, Kuehn MJ. Virulence and immunomodulatory roles of bacterial outer membrane vesicles [J]. M icrobiol Mol Biol Rev, 2010. 74 (1) : 81-94.
  • 6Zhang M, Su S, Bhatnagar BK, et al. Prediction and analysis of the protein interactome in Pseudomonas aeruginosa to enable networkbased drug target selection[J]. PLoS One, 2012, 7(7): e41202.
  • 7Hakk i M, Limaye AP, Kim HW, et al. Invasive Pseudomonas aeruginosa infections: high rate of recurrence and mortality after hematopoietic cell transplantation [J]. Bone Marrow Transplant, 2007, 39(11): 687 -693.
  • 8Lyczak JB, Cannon CL, Pier C B. Lung infections associated with cystic fibrosis [J]. Clin M icrobiol Rev, 2002, 15 (2) : 194 - 222.
  • 9Mulcahy LB, Isabella VM, Lewis K. Pseudomonas aeruginosa biofilms in disease[J]. Microb Ecol , 2013, [Epub ahead of print].
  • 10Ellis TN, Leiman SA, Kuehn MJ. Naturally produced outer membrane vesicles from Pseudomonas aeniginosa elicit a potent innate immune response via combined sensing of both lipopolysaccharide and protein components[J]. Infect Immun , 2010, 78 (9) : 3822 - 3831.

共引文献5

同被引文献12

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部